EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection

Jia-Fong Jhang, Yuan-Hong Jiang iD, Teng-Yi Lin, Hann-Chorng Kuo iD

International Journal of Molecular Sciences · 21.12.2023 · 25 (1) · 163

DOI: 10.3390/ijms25010163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.12.2023. Verfasst von Jia-Fong Jhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 970, Taiwan. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Urinary Tract Infections, Platelet-Rich Plasma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Buddhist Tzu Chi Medical Foundation, Hualien Tzu Chi Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using platelet-rich plasma (PRP) injections to treat urological diseases has attracted great attention. This study investigated the impact of cytokine concentrations in PRP on the treatment outcome of patients with recurrent urinary tract infection (rUTI) and interstitial cystitis/bladder pain syndrome (IC/BPS). Forty patients with IC/BPS and twenty-one patients with rUTI were enrolled for four-monthly repeated PRP injections. PRP was collected at the first injection and analyzed with multiplex immunoassays for 12 target cytokines. In patients with IC/BPS, a Global Response Assessment (GRA) score ≥ 2 was defined as a successful outcome. In rUTI patients, ≤2 episodes of UTI recurrence during one year of follow-up was considered a successful outcome. Nineteen (47.5%) patients with IC/BPS and eleven (52.4%) patients with rUTI had successful outcomes. The IC/BPS patients with successful outcomes had significantly lower levels of tumor necrosis factor-α (TNF-α) in their PRP than those with unsuccessful outcomes (p = 0.041). The rUTI patients with successful outcomes also had a lower level of TNF-α (p = 0.025) and a higher level of epidermal growth factor (p = 0.035) and transforming growth factor-β2 (p = 0.024) in PRP than those with unsuccessful outcomes. A lower level of TNF-α in PRP might be a potentially predictive factor of treatment outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystitis, InterstitialUrinary Tract InfectionsPlatelet-Rich PlasmaHumansTumor Necrosis Factor-alphaTreatment OutcomeCytokines

Stichwörter der Autor:innen

biomarkersinflammationprognosisproteins

Substanzen

Tumor Necrosis Factor-alphaCytokines

Autor:innen und Institutionen

  • Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 970, Taiwan.
  • Department of Laboratory Medicine, Hualien Tzu Chi Hospital and Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.

ORCID-Profile: Yuan-Hong Jiang, Hann-Chorng Kuo

Förderung

  • Buddhist Tzu Chi Medical Foundation
  • Hualien Tzu Chi Hospital

Zitieren

APA

Jhang, J. F., Jiang, Y. H., Lin, T. Y., & Kuo, H. C. (2023). The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection. International Journal of Molecular Sciences, 25(1), 163. https://doi.org/10.3390/ijms25010163

Vancouver

Jhang JF, Jiang YH, Lin TY, Kuo HC. The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection. International Journal of Molecular Sciences. 2023;25(1):163. doi:10.3390/ijms25010163

BibTeX
@article{Jhang2023,
  author = {Jhang, Jia-Fong and Jiang, Yuan-Hong and Lin, Teng-Yi and Kuo, Hann-Chorng},
  title = {The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {25},
  number = {1},
  pages = {163},
  doi = {10.3390/ijms25010163}
}
Kostenlos starten →